Data for (Study ST004296)

(Analysis AN007142)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Metabolite	F1	F2
CE(20:5(5Z,8Z,11Z,14Z,17Z))_positive_mode	0.9817	1.0122
Cer(d18:0/26:0)_positive_mode	0.7996	1.1336
Cer(d18:1/22:1(13Z))_positive_mode	1.1413	0.9058
Cer(d18:1/24:1(15Z))_positive_mode	1.1159	0.9227
Cer(d18:2/23:0)_positive_mode	1.1931	0.8713
Cer(d18:2/25:0)_positive_mode	1.1595	0.8937
CL(16:0/16:0/18:0/20:4(5Z,8Z,11Z,14Z))_positive_mode	0.9623	1.0252
CL(16:0/16:0/18:0/22:5(4Z,7Z,10Z,13Z,16Z))_positive_mode	1.1121	0.9253
Coenzyme Q10_positive_mode	1.0354	0.9764
DG(14:0/24:1(15Z)/0:0)_positive_mode	1.1875	0.8750
DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-22:0/0:0)_positive_mode	0.9598	1.0268
DG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)_positive_mode	0.9613	1.0258
Docosanamide_positive_mode	1.0886	0.9409
LysoPC(18:0/0:0)_positive_mode	1.1063	0.9291
LysoPC(18:1(11Z)/0:0)_positive_mode	0.7792	1.1472
LysoPC(20:0/0:0)_positive_mode	0.9641	1.0239
LysoPC(20:1(11Z)/0:0)_positive_mode	0.9034	1.0644
LysoPE(20:0/0:0)_positive_mode	1.0206	0.9863
LysoPE(P-18:0/0:0)_positive_mode	1.1779	0.8814
PC(O-14:0/16:0)_positive_mode	1.1250	0.9167
PC(O-14:0/16:1(9Z))_positive_mode	1.0406	0.9729
PC(P-16:0/14:0)_positive_mode	1.1421	0.9053
PE(P-16:0/22:1(13Z))_positive_mode	1.0326	0.9783
PI(16:0/20:4(8Z,11Z,14Z,17Z))_positive_mode	1.2435	0.8377
PI(18:0/20:3(8Z,11Z,14Z))_positive_mode	1.3042	0.7972
SM(d18:0/16:1(9Z))_positive_mode	1.2215	0.8523
SM(d18:1/17:0)_positive_mode	1.2473	0.8352
Sphinganine_positive_mode	0.5485	1.3010
Sphingosine_positive_mode	1.4106	0.7262
TG(14:0/15:0/24:0)_positive_mode	0.8743	1.0838
TG(14:0/O-18:0/20:3(5Z,8Z,11Z))_positive_mode	1.0699	0.9534
TG(24:1(15Z)/15:0/18:2(9Z,12Z))_positive_mode	0.9748	1.0168
TG(i-16:0/10:0/19:0)_positive_mode	0.9698	1.0202

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1	Sample source:hASCs | Treatment:Osteogenic conditions
F2	Sample source:hASCs | Treatment:Proliferation conditions